Literature DB >> 19171979

Arsenicosis: diagnosis and treatment.

Nilay Kanti Das1, Sujit Ranjan Sengupta.   

Abstract

Diagnosis of arsenicosis relies on both clinical and laboratory criteria, but principally it can be diagnosed on the basis of its cutaneous manifestations. Cutaneous manifestations (melanosis, keratosis, and cutaneous cancers) are essential clues in the diagnosis, and trained dermatologists or arsenic experts are able to clinically confirm a case even without laboratory backup. Although systemic manifestations are not considered as diagnostic hallmarks, yet their presence serves as important telltale signs in arriving at the diagnosis. In countries where laboratory facilities are available, measuring the level of arsenic in drinking water (consumed in the last 6 months), urine, hair, and nails is of immense value. Newer biomarkers of arsenic exposure are being explored to provide early information about arsenic intoxication, of which urinary porphyrin level, blood metallothionein have shown promising results. Controlling the problem of arsenicosis depends on various factors, of which the most important is cessation of intake of arsenic-contaminated water. Deep wells, traditional dug wells, treatment of surface water, rainwater harvesting, and removing arsenic from the contaminated water by arsenic removal plant or arsenic treatment unit are the available options for providing arsenic-free drinking water. The role of nutrition and antioxidants in preventing the onset of symptoms of arsenicosis is also of importance. Nonspecific therapies (e.g., keratolytics for hyperkeratosis) cannot also be ignored and serve as palliative measures. The persons affected need to be followed up at regular intervals to detect the onset of cancers (if any) at the earliest. Role of counseling and education should never be underestimated since absence of public awareness can undermine all efforts of mitigation measures.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19171979     DOI: 10.4103/0378-6323.45098

Source DB:  PubMed          Journal:  Indian J Dermatol Venereol Leprol        ISSN: 0378-6323            Impact factor:   2.545


  11 in total

1.  ADAMTS13 deficiency, despite well-compensated liver functions in patients with noncirrhotic portal hypertension.

Authors:  Ashish Goel; P L Alagammai; Sukesh C Nair; Ian Mackie; Banumathi Ramakrishna; Jayaprakash Muliyil; Shyamkumar N Keshava; C E Eapen; Elwyn Elias
Journal:  Indian J Gastroenterol       Date:  2014-04-24

Review 2.  Cardiovascular effects of arsenic: clinical and epidemiological findings.

Authors:  Francesco Stea; Fabrizio Bianchi; Liliana Cori; Rosa Sicari
Journal:  Environ Sci Pollut Res Int       Date:  2013-09-10       Impact factor: 4.223

Review 3.  Uptake, Metabolic Effects and Toxicity of Arsenate and Arsenite in Astrocytes.

Authors:  Ralf Dringen; Sabrina Spiller; Sarah Neumann; Yvonne Koehler
Journal:  Neurochem Res       Date:  2015-04-11       Impact factor: 3.996

4.  Chronic arsenic poisoning following ayurvedic medication.

Authors:  Benzeeta Pinto; Palvi Goyal; S J S Flora; K D Gill; Surjit Singh
Journal:  J Med Toxicol       Date:  2014-12

5.  Protective effect of Juglans nigra on sodium arsenite-induced toxicity in rats.

Authors:  Solomon E Owumi; Oyeronke A Odunola; Michael A Gbadegesin; Kathleen L Nulah
Journal:  Pharmacognosy Res       Date:  2013-07

6.  Chronic Arsenic Poisoning Probably Caused by Arsenic-Based Pesticides: Findings from an Investigation Study of a Household.

Authors:  Yongfang Li; Feng Ye; Anwei Wang; Da Wang; Boyi Yang; Quanmei Zheng; Guifan Sun; Xinghua Gao
Journal:  Int J Environ Res Public Health       Date:  2016-01-16       Impact factor: 3.390

7.  The broad scope of health effects from chronic arsenic exposure: update on a worldwide public health problem.

Authors:  Marisa F Naujokas; Beth Anderson; Habibul Ahsan; H Vasken Aposhian; Joseph H Graziano; Claudia Thompson; William A Suk
Journal:  Environ Health Perspect       Date:  2013-01-03       Impact factor: 9.031

Review 8.  Incorporating epigenetic data into the risk assessment process for the toxic metals arsenic, cadmium, chromium, lead, and mercury: strategies and challenges.

Authors:  Paul D Ray; Andrew Yosim; Rebecca C Fry
Journal:  Front Genet       Date:  2014-07-16       Impact factor: 4.599

9.  Chronic arsenic trioxide exposure leads to enhanced aggressiveness via Met oncogene addiction in cancer cells.

Authors:  Kushtrim Kryeziu; Christine Pirker; Bernhard Englinger; Sushilla van Schoonhoven; Melanie Spitzwieser; Thomas Mohr; Wilfried Körner; Regina Weinmüllner; Koray Tav; Johannes Grillari; Margit Cichna-Markl; Walter Berger; Petra Heffeter
Journal:  Oncotarget       Date:  2016-05-10

10.  Acute Sodium Arsenite-Induced Hematological and Biochemical Changes in Wistar Rats: Protective Effects of Ethanol Extract of Ageratum conyzoides.

Authors:  Olufunke Eunice Ola-Davies; Akinleye Stephen Akinrinde
Journal:  Pharmacognosy Res       Date:  2016-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.